| Product Name |
Recombinant Human HSD17B14 Protein |
| Product Overview |
This recombinant human HSD17B14 protein includes amino acids 1-270aa of the target gene is expressed in E.coli.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
| Target Uniprot Id |
Q9BPX1 |
| Recommended Name |
L-fucose dehydrogenase |
| Gene Name |
HSD17B14 |
| Synonyms |
17-beta-hydroxysteroid dehydrogenase 14, DHRS10, retSDR3, SDR47C1, |
| Species |
Human |
| Predicted Molecular Mass |
32.4 kDa |
| Expression System |
E.coli |
| Expression Range |
1-270aa |
| Tag |
N-6His |
| Purity |
>95% |
| Formulation |
Lyophilized |
| Buffer |
Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
| Storage Condition |
1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
| Reconstitution Instruction |
Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
| Applications |
Positive Control; Immunogen; SDS-PAGE; WB |
| Research Area |
Metabolism |
| Target Function |
Has NAD-dependent 17-beta-hydroxysteroid dehydrogenase activity. Converts oestradiol to oestrone. The physiological substrate is not known. Acts on oestradiol and 5-androstene-3-beta,17-beta-diol (in vitro). |
| Subcellular Location |
Cytoplasm. |
| Protein Family |
Short-chain dehydrogenases/reductases (SDR) family |
| Tissue Specificity |
Highly expressed in brain, placenta, liver and kidney. |
